Clever Leaves Holdings Inc.

Equities

CLVR

CA1867602031

Pharmaceuticals

Market Closed - OTC Markets 11:47:14 2024-06-21 am EDT 5-day change 1st Jan Change
3.2 USD -9.86% Intraday chart for Clever Leaves Holdings Inc. +0.95% +52.78%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Clever Leaves Holdings Inc.(NasdaqCM:CLVR) dropped from S&P TMI Index CI
Sector Update: Health Care Stocks Mixed in Late Afternoon Trading MT
Sector Update: Health Care MT
Clever Leaves Shares Rise as Brazil Investment Fund Acquires 8.5% Stake Before Nasdaq Delisting MT
Clever Leaves Holdings Inc.(NasdaqCM:CLVR) dropped from NASDAQ Composite Index CI
Top Midday Decliners MT
North American Morning Briefing : Investors Brace for This Week's Earnings, Fed Decision DJ
Clever Leaves to Delist Securities From Nasdaq MT
Clever Leaves Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Clever Leaves Holdings Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Earnings Flash (CLVR) CLEVER LEAVES Reports Q4 Revenue $4.6M MT
An unknown buyer acquired Portuguese farm assets of Clever Leaves Holdings Inc. for $1.5 million. CI
KAC Investments LLC acquired Herbal Brands, Inc. from Clever Leaves Holdings Inc. for $8 million. CI
Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia CI
Transcript : Clever Leaves Holdings Inc., Q3 2023 Earnings Call, Nov 09, 2023
Earnings Flash (CLVR) CLEVER LEAVES Reports Q3 Revenue $3.8M, vs. Street Est of $5.2M MT
Clever Leaves Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Clever Leaves Holdings Inc. Revises Revenue Guidance for the Full Year 2023 CI
Transcript : Clever Leaves Holdings Inc., Q2 2023 Earnings Call, Aug 14, 2023
Earnings Flash (CLVR) CLEVER LEAVES Reports Q2 Revenue $5M, vs. Street Est of $5M MT
Clever Leaves Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Clever Leaves Holdings Inc. Reiterates Earnings Guidance for the Year 2023 CI
Clever Leaf Holdings Inc. Announces Colombian Flower Is Now Available to Australian Patients Through Strategic Partnership with Australian Natural Therapeutics Group CI
Clever Leaves Holdings Inc.(NasdaqCM:CLVR) dropped from Russell 3000E Value Index CI
Clever Leaves Holdings Inc.(NasdaqCM:CLVR) dropped from Russell 3000E Index CI
Chart Clever Leaves Holdings Inc.
More charts
Clever Leaves Holdings Inc. is a multinational operator and licensed producer of pharmaceutical-grade cannabinoids. The Company's segments include Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is comprised of cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products. The Non-Cannabinoid operating segment is comprised of the brands and manufacturing assets acquired as part of its acquisition of Herbal Brands. The Non-Cannabinoid segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing wellness products and nutraceuticals, excluding cannabinoid products. Its customers for the Herbal Brands products include specialty and health retailers, mass retailers and specialty and health stores in the United States. It offers product portfolio in two categories: nutraceuticals and cannabinoids. The nutraceutical products consist of a variety of beverage and powder products.
More about the company